Novo Nordisk A/S
F:NOVC

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
F:NOVC
Watchlist
Price: 90.7 EUR -1.52%
Market Cap: 203.5B EUR

P/FCFE
Price to FCFE

16.4
Current
32.9
Median
22.8
Industry
Lower than median
Lower than industry value

The Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company’s market value to the free cash flow available to its shareholders. It’s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
16.4
=
Market Cap
1.6T DKK
/
FCFE
98.6B DKK
All Countries
Close

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A